Published in Lancet Oncol on March 01, 2012
External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours. Br J Cancer (2013) 1.17
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol (2015) 0.87
Borderline ovarian tumors and diagnostic dilemma of intraoperative diagnosis: could preoperative He4 assay and ROMA score assessment increase the frozen section accuracy? A multicenter case-control study. Biomed Res Int (2014) 0.84
Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes. Mod Pathol (2012) 0.83
Port-site metastasis of mucinous borderline ovarian tumor after laparoscopy. Case Rep Oncol (2014) 0.78
Epithelial borderline ovarian tumor: Diagnosis and treatment strategy. Obstet Gynecol Sci (2015) 0.78
Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment. Ecancermedicalscience (2013) 0.78
Fertility sparing treatment in borderline ovarian tumours. Ecancermedicalscience (2015) 0.78
Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer. Sci Rep (2016) 0.76
Mucinous Borderline Ovarian Tumor in Very Old Aged Postmenopausal Woman. J Menopausal Med (2015) 0.75
The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review. J Cancer (2017) 0.75
Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age. Obstet Gynecol Sci (2017) 0.75
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol (2008) 2.23
Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging. Clin Breast Cancer (2010) 2.12
Gynaecological cancers in pregnancy. Lancet (2012) 2.11
Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer (2003) 2.01
The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis. Am J Obstet Gynecol (2012) 2.01
Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol (2009) 1.77
Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes. Ann Surg Oncol (2004) 1.75
Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease. Radiology (2004) 1.72
Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Lancet Oncol (2009) 1.68
Quality of life after laparoscopic colorectal resection for endometriosis. Hum Reprod (2006) 1.66
Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol (2008) 1.54
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol (2010) 1.53
Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol (2007) 1.52
Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas. Surgery (2005) 1.51
Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol (2007) 1.50
Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants. Gynecol Oncol (2005) 1.49
French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer (2009) 1.48
Sentinel lymph nodes of colorectal carcinoma: reappraisal of 123 cases. Gastroenterol Clin Biol (2007) 1.48
Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. J Clin Oncol (2009) 1.48
A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. Gynecol Oncol (2005) 1.41
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg (2003) 1.40
First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients. Gynecol Oncol (2004) 1.37
Are G3 ENETS neuroendocrine neoplasms heterogeneous? Endocr Relat Cancer (2013) 1.31
An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat (2005) 1.27
Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: case report and review of the literature. Fertil Steril (2007) 1.22
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol (2011) 1.20
Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol (2005) 1.18
Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg (2003) 1.13
Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab (2006) 1.13
Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res (2005) 1.11
Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol (2012) 1.08
Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol (2008) 1.08
Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Ann Surg Oncol (2007) 1.08
Determinants of patient dissatisfaction after a tension-free vaginal tape procedure for urinary incontinence. J Urol (2002) 1.08
MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. AJR Am J Roentgenol (2003) 1.07
Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol (2005) 1.07
Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence. Anticancer Res (2009) 1.05
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist (2010) 1.05
Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery (2003) 1.05
Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis (2006) 1.04
Growing teratoma syndrome after ovarian germ cell tumors. Obstet Gynecol (2006) 1.02
Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think... Ann Surg (2010) 1.02
Metastatic tumors to the colon and rectum: a multi-institutional study. Arch Pathol Lab Med (2012) 1.02
Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril (2007) 1.02
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma. Endocr Relat Cancer (2009) 1.01
Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update (2012) 1.00
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study. Int J Gynecol Cancer (2012) 0.99
Malignant female adnexal tumor of probable wolffian origin relapsing after pregnancy. Gynecol Oncol (2004) 0.98
Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer (2004) 0.96
A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol (2012) 0.96
[Peritoneal glioblastoma: recurrence of ovarian immature teratoma (report of a case)]. Ann Pathol (2002) 0.95
An appendix carcinoid tumor in a patient with hereditary nonpolyposis colorectal cancer. Hum Pathol (2004) 0.94
Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg (2002) 0.94
Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours. J Surg Oncol (2005) 0.94
Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern. Ann Surg Oncol (2008) 0.94
Primary psammocarcinoma of the ovary or peritoneum. Int J Gynecol Cancer (2009) 0.94
3D-conformal accelerated partial breast irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity. Radiat Oncol (2009) 0.94
[Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy]. Gastroenterol Clin Biol (2003) 0.93
Intra-abdominal desmoplastic small round cell tumors: CT findings and clinicopathological correlations in 13 cases. Eur J Radiol (2005) 0.93
Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Breast Cancer Res Treat (2008) 0.92
Adrenalectomy for clinically isolated metastasis from colorectal carcinoma: report of eight cases. Dis Colon Rectum (2008) 0.92
Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells. Am J Pathol (2012) 0.92
Symptoms before and after surgical removal of colorectal endometriosis that are assessed by magnetic resonance imaging and rectal endoscopic sonography. Am J Obstet Gynecol (2004) 0.91
Prognostic value of lymph node involvement in ovarian serous borderline tumors. Am J Obstet Gynecol (2011) 0.90
Placental site and epithelioid trophoblastic tumours: diagnostic pitfalls. Gynecol Oncol (2012) 0.90
Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary. Oncologist (2011) 0.90
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer (2010) 0.90
Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Int J Radiat Oncol Biol Phys (2008) 0.89
Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol (2005) 0.89
Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients. Surg Endosc (2013) 0.89
Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy. Radiother Oncol (2008) 0.88
Management and prognosis of borderline ovarian Brenner tumors. Int J Gynecol Cancer (2012) 0.88
Gliomatosis peritonei: a particular entity with specific outcomes within the growing teratoma syndrome. Int J Gynecol Cancer (2015) 0.88
Mixed nonseminomatous germ cell tumor presenting as a subcutaneous tissue mass. Am J Dermatopathol (2006) 0.88
Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features. Cancer (2007) 0.88
Villoglandular papillary adenocarcinoma of the cervix: a series of 28 cases including two with lymph node metastasis. Int J Gynecol Cancer (2013) 0.88
Cancer in pregnancy: a challenging conflict of interest. Lancet (2012) 0.88